[Beta-receptor-blocking agents and their current clinical significance].
D000310:Adrenal Gland Neoplasms / Q000188:drug therapy; D000605:Amino Alcohols / Q000494:pharmacology; D000787:Angina Pectoris / Q000188:drug therapy; D000813:Anilides / Q000494:pharmacology; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D004983:Ethanolamines / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006329:Heart Conduction System / Q000187:drug effects; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007545:Isoproterenol / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010673:Pheochromocytoma / Q000188:drug therapy; D011433:Propranolol / Q000494:pharmacology; D013116:Spinal Cord / Q000187:drug effects; D013451:Sulfonic Acids / Q000494:pharmacology; D013565:Sympatholytics / Q000009:adverse effects / Q000627:therapeutic use*; D013771:Tetralogy of Fallot / Q000188:drug therapy
D000605:Amino Alcohols; D000813:Anilides; D004983:Ethanolamines; D010627:Phenethylamines; D013451:Sulfonic Acids; D013565:Sympatholytics; D011433:Propranolol; D008729:Methoxamine; D007545:Isoproterenol; D009638:Norepinephrine
Beta-Rezeptorenblocker und ihre gegenwärtige klinische Beutung.